In VivoBiosafety Model to Assess the Risk of Adverse Events From Retroviral and Lentiviral Vectors

Serious adverse events in some human gene therapy clinical trials have raised safety concerns when retroviral or lentiviral vectors are used for gene transfer. We evaluated the potential for generating replication-competent retro-virus (RCR) and assessed the risk of occurrence of adverse events in a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Molecular therapy 2008-05, Vol.16 (7), p.1308-1315
Hauptverfasser:	Bauer, Gerhard, Dao, Mo A, Case, Scott S, Meyerrose, Todd, Wirthlin, Louisa, Zhou, Ping, Wang, Xiuli, Herrbrich, Phillip, Arevalo, Jesusa, Csik, Susie, Skelton, Dianne C, Walker, Jon, Pepper, Karen, Kohn, Donald B, Nolta, Jan A
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!